Open Accessibility Menu

Monthly investment news and growth insights — straight to your inbox. Sign up to our newsletter.

NanoSyrinx

Life Sciences  •  East of England  •  Early Stage

NanoSyrinx is a synthetic biology company, developing 'nanosyringes' as a novel platform technology for the targeted intracellular delivery of biological molecules.

nanosyrinx.com

Company
information

Investment date

August 2024

Head office

Cambridge

CEO

Dr. Joe Healey